Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients. 2013

Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
Department of Colorectal Surgery, China Medical University Hospital, Taichung, Taiwan.

BACKGROUND Colorectal cancer metastasis is a multistep process involving degradation of extracellular matrix components by proteolytic enzymes. Among them, matrix metalloproteinases (MMPs) are the principal degrading enzymes and their expressions/activities are also correlated with survival. Much research has showed the associations between genetic polymorphisms in MMPs and risk of colorectal cancer; however, their prognostic significance has not been well determined. METHODS We selected and genotyped 4 cancer-associated single nucleotide polymorphisms (SNPs) in a cohort of 282 colorectal cancer patients. The associations of these SNPs with distant metastasis-free survival and overall survival were evaluated by Kaplan-Meier analysis, Cox regression model, and survival tree analysis. RESULTS The relative risks of developing distant metastasis after curative surgery were higher in individuals with minor homozygote AA genotype than in those with GG/GA genotypes at MMP2 rs243866 (P = 0.012). Survival tree analysis also identified a higher-order genetic interaction profile consisting of MMP2 rs243866 and MMP2 rs2285053 that was significantly associated with distant metastasis-free survival (P trend = 0.016). After adjusting for possible confounders, the genetic interaction profile remained significant (P trend = 0.050). CONCLUSIONS These results suggest that genetic variations in the MMP2 might be potential predictors of distant metastasis-free survival after curative surgery.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms
D020782 Matrix Metalloproteinases A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components. MMP,MMPs,Matrix Metalloproteinase,Metalloproteinase, Matrix,Metalloproteinases, Matrix

Related Publications

Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
March 2008, Clinical genetics,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
December 2003, Medizinische Klinik (Munich, Germany : 1983),
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
February 2002, Clinical colorectal cancer,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
April 2017, Oncology letters,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
May 2009, The Journal of urology,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
May 1996, Biochemical Society transactions,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
September 2015, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
September 2021, Clinical oral investigations,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
January 2004, Cancer metastasis reviews,
Wen-Chien Ting, and Lu-Min Chen, and Jiunn-Bey Pao, and Ying-Pi Yang, and Bang-Jau You, and Ta-Yuan Chang, and Yu-Hsuan Lan, and Hong-Zin Lee, and Bo-Ying Bao
February 2014, Cancers,
Copied contents to your clipboard!